The swine flu vaccine approved for use in Canada by the country’s federal drug regulator does not use aborted fetal cell lines in its manufacture.

The vaccine is produced by GlaxoSmithKline under the trade name Arepanrix, and is made with chick embryos.

Health Canada’s Arepanrix product information leaflet says the “H1N1 antigen is prepared from virus grown in the allantoic cavity of embryonated hen’s eggs.”

This is welcome news for those considering the swine flu shot.